GLP-1 medications: A comprehensive overview
With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.
14 hours ago
0
0
MeSH tree: D27.505.696.422.125
With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.
14 hours ago
0
0
For the second year in a row, the Dietary Approaches to Stop Hypertension, or DASH Diet, developed in part by scientists at Pennington Biomedical Research Center, has been recognized as the best heart-healthy diet in the ...
Jan 15, 2026
0
35
Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal thoughts, and they have asked drugmakers to remove those warnings from medication labels.
Jan 15, 2026
0
0
Obstacles to preventing and treating obesity, including limited access to healthy foods, limited time to prepare meals and exercise, neighborhood factors, weight stigma and financial constraints, are more likely to affect ...
Jan 15, 2026
0
0
When endocrinologist Dan Bessesen, MD, looked online and saw how easy it would be for him to purchase a weight loss drug from a compounding pharmacy without being seen by a medical provider, he was disturbed.
Jan 14, 2026
0
0
Many low-income Californians prescribed wildly popular weight loss drugs lost their coverage for the medications at the start of the new year.
Jan 13, 2026
0
0
Weight-loss drugs such as Ozempic, Wegovy and Mounjaro work primarily by reducing hunger. They mimic a hormone the body already produces called glucagon-like peptide-1 (GLP-1), which helps regulate appetite and feelings of ...
Jan 12, 2026
0
0
When people stop taking the new generation of weight-loss drugs they pile back on the kilos four times faster than they would after ending diet and exercise regimens, new research found Thursday.
Jan 11, 2026
0
1
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which most drugs and interventions in the U.S. are approved.
Jan 10, 2026
0
0
The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in weight-related diseases like diabetes, cardiovascular disease, and cancers. This public health crisis strains ...
Jan 8, 2026
0
22